December 8, 2004 |
An Amgen Inc. drug increased the number of platelets -- blood cells needed for clotting -- in patients with an uncommon immune disorder, according to research presented at a medical meeting in San Diego. A larger company-funded study is underway to test AMG 531 in patients with immune thrombocytopenic purpura, which causes the immune system to destroy platelets, said lead investigator David Kuter of Massachusetts General Hospital. About 20,000 people in the U.S.
July 25, 1995
Biopool International Inc., a Ventura producer of medical test kits, said it has developed a new test that would pinpoint people at risk for heart attacks and strokes. The test was presented at a research conference in Israel last month, and focuses on blood platelets. Using the new test, researchers mix the antibodies of chickens with human blood platelets for analysis. The results screen out those at high risk of cardiovascular ailments.
January 10, 2004 |
Scientists have found an odd, light-reflecting protein in the body of a squid that could one day prove useful in the design of microscopic optic devices. The discovery, reported in the current issue of Science, was made by researchers at the University of Hawaii and UCLA investigating the light-emitting organ of Euprymna scolopes, the Hawaiian bobtail squid.
January 24, 1995 |
Ever found a mysterious black-and-blue mark on your body and wondered how it gotthere? Whether the result of major trauma or an inadvertent bump, bruising is one way to assess damage to tissue. The factors involved in what makes a bruise and how it heals are fairly simple. In an effort to get to the bottom of bruising, we went to three specialists who deal in bruises: Dr. Philomena McAndrew, a Los Angeles hematologist; Dr. William Shankwiler, a Pasadena orthopedic surgeon, and Dr.
June 25, 1995 |
There are never enough blood, marrow or organ donors. Even as the American Red Cross emphasizes the need for more Latino blood donors, it and other agencies continue to hope for more donors of all ethnic groups to help cope with a variety of illnesses or emergencies. "People are not aware of the process of organ donations," said Nancy Fox, a director at the Regional Organ Procurement Agency of Southern California (ROPA). "Families are not aware of the wishes of their loved ones."
September 13, 2012 |
Dr. Anthony Atala, director of the Wake Forest Institute for Regenerative Medicine, is used to hearing his work described as science fiction. Way back in 1999, he and his team grew bladders in a lab and successfully implanted them in patients with spina bifida. Then in 2004, his team grew urethras for five young boys in Mexico City. Eight years later, the laboratory-grown tissue looks as natural as the boys' own. At the rate research like Atala's is progressing, scientists predict that replacement organs will be a reality within years, not decades.
December 5, 1995
Amgen Inc. has reported encouraging results in its first human tests of a new drug called MGDF that triggers production of platelets in the blood. If MGDF works, it is hoped that the biotechnology drug will allow doctors to treat cancer patients undergoing chemotherapy who suffer from bleeding and hemorrhages because their blood platelets will not clot. Current medical treatment is to reduce chemotherapy and give patients platelet transfusions.